Targeting CDK7 in oncology: The avenue forward.

Li, Zhi-Mei; Liu, Guan; Gao, Ya; Zhao, Ming-Gao

Li, Zhi-Mei; Liu, Guan; Gao, Ya; Zhao, Ming-Gao.

Afiliación

Li ZM; Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, PR China.
Liu G; Department of General Surgery, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 1, Xi'an 710038, Shaanxi, PR China.
Gao Y; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education of China, Key Laboratory of Henan Province for Drug Quality and Evaluation, Institute of Drug Discovery and Development, School of Pharmaceutical Scienc
Zhao MG; Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, Shaanxi, PR China; Department of Pharmacy, Tangdu Hospital, Fourth Military Medical University, Xinsi Road 1, Xi'an 710038, Shaanxi, PR China. Electronic address: minggao@fmmu.edu.cn.

Pharmacol Ther ; 240: 108229, 2022 12.

Article en En | MEDLINE | ID: mdl-35700828

Asunto(s)

Neoplasias; Humanos; Ciclo Celular; Neoplasias/metabolismo; Descubrimiento de Drogas

Palabras clave

Anti-cancer treatment; CDK7; CDK7 inhibitors; Therapeutic target

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Límite: Humans Idioma: En Revista: Pharmacol Ther Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google